Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
2.53M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
25.4M
-
Shares change
-
-816K
-
Total reported value, excl. options
-
$13.1M
-
Value change
-
-$391K
-
Number of buys
-
10
-
Number of sells
-
-15
-
Price
-
$0.51
Significant Holders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) as of Q1 2024
49 filings reported holding OMIC - Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value as of Q1 2024.
Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.4M shares
.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4.98M shares), ARCH Venture Management, LLC (3.8M shares), QVIDTVM Management LLC (2.51M shares), UBS Group AG (2.21M shares), PERCEPTIVE ADVISORS LLC (2.13M shares), FMR LLC (2.12M shares), VANGUARD GROUP INC (1.87M shares), Casdin Capital, LLC (1.32M shares), BlackRock Inc. (739K shares), and ORBIMED ADVISORS LLC (541K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.